Lei Tu et al. showed that high expression of PD-1, CTLA-4, LAG-3, and TIM-3 is a good prognostic marker in patients with breast cancer who received chemotherapy, and higher ICRs expressions were detected on TILs of these patients [26]. The gene discussed is HAVCR2; the disease is breast carcinoma.